Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-10-30

Clinical Trial Update: Radiation Therapy With or Without Thalidomide in Treating Patients With Brain Metastases [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating radiation therapy with or without thalidomide for brain metastases has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Thalidomide (thalidomide)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Tumors Metastatic to Brain | Phase 3 | Status: COMPLETED